Predictive and prognostic value of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin

被引：1
|
作者：
Wang, R-X [1 ]
Chen, S. [1 ]
Jin, X. [1 ]
Shao, Z-M [1 ]
机构：
[1] Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P5-16-13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-16-13
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [31] The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
    Robin L. Jones
    Janine Salter
    Roger A’Hern
    Ash Nerurkar
    Marina Parton
    Jorge S. Reis-Filho
    Ian E. Smith
    Mitchell Dowsett
    Breast Cancer Research and Treatment, 2009, 116 : 53 - 68
  • [32] The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
    Jones, Robin L.
    Salter, Janine
    A'Hern, Roger
    Nerurkar, Ash
    Parton, Marina
    Reis-Filho, Jorge S.
    Smith, Ian E.
    Dowsett, Mitchell
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (01) : 53 - 68
  • [33] Value of Ki-67 in prediction of response to neoadjuvant chemotherapy in breast cancer
    Kim, Kwanil
    Lee, Kyunghee
    Park, Heungkyu
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [34] P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients
    Pan, Yunbao
    Yuan, Yufen
    Liu, Guoshi
    Wei, Yongchang
    PLOS ONE, 2017, 12 (02):
  • [35] Prognostic estimates of Ki-67 percentage drop after neoadjuvant chemotherapy (NAC) in luminal B (lumB) and triple negative breast cancer (TNBC)
    Pascual, J.
    Rojas-Garcia, B.
    Peg, V.
    Diaz-Botero, S.
    Zamora, E.
    Munoz Couselo, E.
    Oliveira, M.
    Gomez Pardo, P.
    Perez Garcia, J.
    Ruiz-Pace, F.
    Viaplana, C.
    Escriva, S.
    Garrigos, L.
    Arumi, M.
    Espinosa-Bravo, M.
    Cortes, J.
    Rubio, I.
    Saura, C.
    Dienstmann, R.
    Bellet Ezquerra, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [36] Change of Ki-67 after long course of neoadjuvant chemotherapy as prognostic factors in patients with stage II, III triple negative breast cancer
    Yang, Yaewon
    Kim, Tae-Yong
    Im, Seock-Ah
    Keam, Bhumsuk
    Lee, Kyung-Hun
    Han, Sae-Won
    Oh, Do-Youn
    Kim, Tae-You
    Moon, Hyeong-Gon
    Han, Wonshik
    Park, In Ae
    Noh, Dong-Young
    CANCER RESEARCH, 2015, 75
  • [37] Prognostic value of Ki-67 proliferating index in triple negative breast carcinomas
    Mrklic, Ivana
    Capkun, Vesna
    Pogorelic, Zenon
    Tomic, Snjezana
    PATHOLOGY RESEARCH AND PRACTICE, 2013, 209 (05) : 296 - 301
  • [38] Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients
    Ruo-Xi Wang
    Sheng Chen
    Liang Huang
    Zhi-Ming Shao
    BMC Cancer, 18
  • [39] Predictive and prognostic value of Matrix metalloproteinase (MMP)-9 in neoadjuvant chemotherapy for triple-negative breast cancer patients
    Wang, Ruo-Xi
    Chen, Sheng
    Huang, Liang
    Shao, Zhi-Ming
    BMC CANCER, 2018, 18 : 1 - 8
  • [40] Claudin 4 expression in triple-negative breast cancer: correlation with androgen receptors and Ki-67 expression
    Abd-Elazeem, Mona A.
    Abd-Elazeem, Marwa A.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2015, 19 (01) : 37 - 42
12345